Combination of an FXR agonist and an ACC inhibitor increases anti-fibrotic efficacy in rodent models of NASHJ. Bates, D. Hollenback, A. Zagorska,G.R. Budas,J.T. Liles,H. Liu,K. Liu, S. Kusam,R. Brockett, D. Newstrom,I. Mikaelian,T. Wang,A. Ray,D.G. BreckenridgeJOURNAL OF HEPATOLOGY(2018)引用 2|浏览20暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要